Liren Li

State Key Laboratory Of Oncology In South China
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.

p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.

Journal: Cancer cell
Published: February 01, 2026

Erratum: Investigation of the role and mechanism of ARHGAP5-mediated colorectal cancer metastasis: Erratum.

Erratum: Investigation of the role and mechanism of ARHGAP5-mediated colorectal cancer metastasis: Erratum.

Journal: Theranostics
Published: February 03, 2025

Neoadjuvant treatment of IBI310 plus sintilimab in locally advanced MSI-H/dMMR colon cancer: A randomized phase 1b study.

Neoadjuvant treatment of IBI310 plus sintilimab in locally advanced MSI-H/dMMR colon cancer: A randomized phase 1b study.

Journal: Cancer cell
Published: November 28, 2024

Short-Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.

Short-Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.

Journal: MedComm
Published: May 26, 2024

Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I-IV colorectal cancer.

Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I-IV colorectal cancer.

Journal: Therapeutic advances in medical oncology
Published: July 18, 2023

Computational profiling and prognostic modeling based on lysosome-related genes in colorectal cancer.

Computational profiling and prognostic modeling based on lysosome-related genes in colorectal cancer.

Journal: Frontiers in genetics
Published: May 05, 2023

Neurotransmitter receptor-related gene signature as potential prognostic and therapeutic biomarkers in colorectal cancer.

Neurotransmitter receptor-related gene signature as potential prognostic and therapeutic biomarkers in colorectal cancer.

Journal: Frontiers in cell and developmental biology
Published: April 07, 2023

Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer.

Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer.

Journal: Oncoimmunology
Published: January 12, 2023

A novel TOX3-WDR5-ABCG2 signaling axis regulates the progression of colorectal cancer by accelerating stem-like traits and chemoresistance.

A novel TOX3-WDR5-ABCG2 signaling axis regulates the progression of colorectal cancer by accelerating stem-like traits and chemoresistance.

Journal: PLoS biology
Published: September 23, 2022

Delineating the molecular landscape of different histopathological growth patterns in colorectal cancer liver metastases.

Delineating the molecular landscape of different histopathological growth patterns in colorectal cancer liver metastases.

Journal: Frontiers in immunology
Published: September 15, 2022

Impact of defecation dysfunction on quality of life in mid-low rectal cancer patients following sphincter-sparing surgery.

Impact of defecation dysfunction on quality of life in mid-low rectal cancer patients following sphincter-sparing surgery.

Journal: Asia-Pacific journal of oncology nursing
Published: March 05, 2022

A novel score system for predicting conversion to no evidence of Disease (C-NED) in initially unresectable colorectal cancer liver metastases.

A novel score system for predicting conversion to no evidence of Disease (C-NED) in initially unresectable colorectal cancer liver metastases.

Journal: American journal of cancer research
Published: January 15, 2022
Showing 1-12 of 33

Last Updated: 09/26/2026